However, results can be different for each person
The finding that GLP1-RA users not using DPP-4 inhibitors had better reduction of anxiety was somewhat surprising
Keep the vials away from direct light, extreme temperatures, and humidity
Polymorphism of the MTHFR (C677T), MTRR (A66G) and methionine synthase (A2756G) genes have been studied extensively in families who have members with spina bifida and compared to individuals from unaffected families [36,39,40,41,59]
Skin reactions may result from: Immune-mediated hypersensitivity to the active semaglutide molecule itself Reactions to pharmaceutical excipients , particularly phenol or other preservatives Local tissue irritation from the subcutaneous injection process Formation of anti-drug antibodies , though this occurs in fewer than 1% of patients according to the EMA European Public Assessment Report (EPAR) for Ozempic Factors that may potentially increase susceptibility to Ozempic skin reactions include: Previous allergic reactions to other GLP-1 receptor agonists (such as liraglutide or dulaglutide) History of atopic conditions although evidence specifically linking atopy to increased risk of semaglutide reactions is limited Multiple drug allergies or known hypersensitivity to injectable medications Improper injection technique , such as injecting too superficially or failing to rotate injection sites Concurrent skin conditions at the injection site To minimise injection site reactions, avoid injecting into areas of infection, lipodystrophy, scars or active dermatitis
